Arcellx, Inc. (ACLX)

115.05 -0.05 (-0.04%) USD  |  NASDAQ  |  Apr 17, 16:00
115.07 +0.02 (+0.02%) After-Hours: 20:00
More

Arcellx Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade